Company Profile
RUA Life Sciences develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. Its business is organized into four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart.
The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil Provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric, as well as the development and commercialization of bore polymer sealed grafts and soft tissue patches
Development of tri-leaflet polymeric heart valves. Incorporated in 1996 and headquartered in Irvine, the United Kingdom, RUA Life Sciences was formerly known as AorTech International plc before rebranding in June 2020.